Evidence map›Paper›PMID 32321202›Full record

ReviewGut and liver2021

Characteristics and Early Diagnosis of Gastric Cancer Discovered after

Masanori Ito, Shinji Tanaka, Kazuaki Chayama

Open access · diamondAbstract readReview
In one paragraph

Review in Gut and liver, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Rapid diagnosis ofFrontiers in public health · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. iScience · 2024
    Article
  9. Research advances in the molecular classification of gastric cancer.Cellular oncology (Dordrecht, Netherlands) · 2024
    Review
  10. Article
  11. Article
  12. Research progress on molecular mechanism of pyroptosis caused byAnnals of medicine and surgery (2012) · 2024
    Review
  13. Cancers · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Masanori ItoDepartment of General Internal Medicine, Hiroshima University Hospital, Hiroshima, Japan.ORCID 0000-0002-8218-9059
Shinji TanakaDepartment of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.ORCID 0000-0002-0480-3957
Kazuaki ChayamaDepartment of Gastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan.ORCID 0000-0002-5530-5341
Hiroshima University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence of gastric cancer after eradication (GCAE) is increasing dramatically in Japan. GCAE has characteristic features, and we must understand these features in endoscopic examinations. Differentiated cancer types were frequently found after eradication and included characteristic endoscopic features such as reddish depression (RD). However, benign RD can be difficult to distinguish from gastric cancer because of histological alterations in the surface structures (nonneoplastic epithelium or epithelium with low-grade atypia [ELA]) as well as multiple appearances of RD. Recently, we clarified similar alterations in genetic mutations between ELA and gastric cancer, suggesting that ELA is derived from gastric cancer. Clinically, submucosal invasive cancer was frequently found in patients after eradication therapy even if they received annual endoscopic surveillance. We can improve the diagnostic ability using image-enhanced endoscopy with magnified observation.

Indexed as

Helicobacter InfectionsHelicobacter pyloriStomach NeoplasmsEarly Detection of CancerGastric MucosaHumansEpithelium with low-grade atypiaEradication therapyHelicobacter pyloriReddish depressionStomach neoplasms

Identifiers

PMID32321202
PMCPMC8129660
OpenAlexW3019111276

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.